We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Atrial Fibrillation Often Recurs After Ablation

By HospiMedica International staff writers
Posted on 25 Apr 2012
Two-thirds of patients with atrial fibrillation (AF) who underwent catheter ablation had recurrence during the first year after ablation, according to a new study.

Researchers at Beth Israel Deaconess Medical Center (Boston, MD, USA) evaluated the long-term outcomes of 153 catheter ablations in 103 AF patients with drug refractory AF (mean age 53, mean BMI 29 kg/m2, and more than three-quarters men); follow up was for six years. More...
In all, 42 patients needed a second ablation, seven patients required a third ablation procedure, and one patient required a fourth ablation. Major bleeding followed 4% of all procedures, but there were no deaths, cerebrovascular (CV) events, or symptomatic pulmonary vein stenoses during follow-up. The researcher defined AF recurrence as atrial arrhythmia lasting more than 10 seconds.

The results showed that at one year after the last ablation, 63% of patients were free of all atrial arrhythmias; but by six years, that proportion had fallen to 39%. Of those who had more than one ablation procedure, the only predictor of recurrence was nonparoxysmal AF. After 62 ablation procedures, the patients were weaned off antiarrhythmic drugs, but AF recurred after 54 of those 62 cases (87%). The study was published early online on January 14, 2012, in the American Journal of Cardiology.

“Long-term results of catheter ablation for AF are somewhat disappointing compared with the short and medium-term ones,” said lead author Antonio Sorgente, MD. “Long-term free arrhythmia survival can be prolonged by not treating patients with nonparoxysmal AF, with enlarged atria, and with advanced cardiomyopathy; an accurate patient selection may help cardiac electrophysiologists reducing the rate of complications as well.”

AF may occur in episodes lasting from minutes to days (paroxysmal), or be permanent in nature (nonparoxysmal).

Related Links:

Beth Israel Deaconess Medical Center




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.